{"entity":{"type":"insider","cik":"0001661486","url":"/insider/0001661486","json_url":"/insider/0001661486.json","name":"Celgene Switzerland LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2017-02-01","last":"2019-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Celgene Switzerland LLC","source":"filing","n_filings":5,"first_seen":"2017-02-01","last_seen":"2019-11-14"}],"transactions":[{"id":8116084,"accession":"0001104659-19-064171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-064171","line_url":"/filing/0001104659-19-064171#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene European Investment Co LLC; Celgene Alpine Investment Co., LLC; Celgene Switzerland LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":403225.0,"shares_display":"403,225","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":12499975.0,"total_display":"12,499,975.00","total_whole":"12,499,975","shares_owned_after":1777824.0,"shares_owned_after_display":"1,777,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-14","scope":"insider"},{"id":9270523,"accession":"0001209191-18-006131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-006131","line_url":"/filing/0001209191-18-006131#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene Alpine Investment Co., LLC; Celgene European Investment Co LLC; Celgene Switzerland LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":851154.0,"shares_display":"851,154","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":57027318.0,"total_display":"57,027,318.00","total_whole":"57,027,318","shares_owned_after":1374599.0,"shares_owned_after_display":"1,374,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-31","scope":"insider"},{"id":6232371,"accession":"0001209191-18-004895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004895","line_url":"/filing/0001209191-18-004895#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"Celgene Switzerland LLC; Celgene Alpine Investment Co., LLC; CELGENE CORP /DE/; Celgene European Investment Co LLC","owner_display_name":"Celgene Switzerland LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":851154.0,"shares_display":"851,154","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":57027318.0,"total_display":"57,027,318.00","total_whole":"57,027,318","shares_owned_after":1374599.0,"shares_owned_after_display":"1,374,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-23","scope":"insider"},{"id":4777701,"accession":"0001209191-17-027983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-027983","line_url":"/filing/0001209191-17-027983#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"Celgene Alpine Investment Co., LLC; CELGENE CORP /DE/; Celgene Switzerland LLC; Celgene European Investment Co LLC","owner_display_name":"Celgene Alpine Investment Co., LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":624575.0,"shares_display":"624,575","price_per_share":49.5,"price_display":"49.50","price_state":"stated","total_value":30916462.5,"total_display":"30,916,462.50","total_whole":"30,916,463","shares_owned_after":1856353.0,"shares_owned_after_display":"1,856,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-24","scope":"insider"},{"id":5308551,"accession":"0001209191-17-006676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-006676","line_url":"/filing/0001209191-17-006676#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":null,"owner_name":"CELGENE CORP /DE/; Celgene Switzerland LLC","owner_display_name":"CELGENE CORP /DE/","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":3456463.0,"shares_owned_after_display":"3,456,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Ten percent owner","n_filings":4,"first_seen":"2017-04-24","last_seen":"2019-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Ten percent owner","n_filings":1,"first_seen":"2017-02-01","last_seen":"2017-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001661486","retrieved_at":"2026-08-25T03:31:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}